Tuesday, January 26, 2010 9:27:48 PM
The reason some of us are waiting on the edge of our seat for the validation company report (not with specifics but with their stamp of approval) is precisely that: a company in and of itself shouldn't be the only source of information. I'm holding my shares tightly because I believe that by the end of Feb. other sources will be in agreement with JBII's assessment of their process.
I disagree with you on their long term economic viability. IF things go even half as well, a quarter as well!, is currently being planned then their is huge economic (and environmental) upside. Check out EP's price matrix for yourself on that one.
I've seen this company compared to new biotech companies. Their price is determined on hype and potential until the FDA, or whoever, approves their drug. That's what we are waiting on....approval. The price mainly reflects the hype and potential of what JB is trying to build.
I hope you hold at least a few shares as I think you will be very happy in a few months. If not that's ok too.
- Oh yeah, if we turn water into air what are we going to turn into water?
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM